Literature DB >> 11797800

Biological significance of glycosylation of the envelope protein of Kunjin virus.

J H Scherret1, J S Mackenzie, A A Khromykh, R A Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11797800     DOI： 10.1111/j.1749-6632.2001.tb02719.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  27 in total

1.  West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.

Authors:  Justin A Roby; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity.

Authors:  Judith Edmonds; Erinke van Grinsven; Natalie Prow; Angela Bosco-Lauth; Aaron C Brault; Richard A Bowen; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

3.  Mutations in the West Nile prM protein affect VLP and virion secretion in vitro.

Authors:  Amanda E Calvert; Claire Y-H Huang; Carol D Blair; John T Roehrig
Journal:  Virology       Date:  2012-07-31       Impact factor: 3.616

4.  Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.

Authors:  Kevin Whitby; Theodore C Pierson; Brian Geiss; Kelly Lane; Michael Engle; Yi Zhou; Robert W Doms; Michael S Diamond
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.

Authors:  David W C Beasley; Melissa C Whiteman; Shuliu Zhang; Claire Y-H Huang; Bradley S Schneider; Darci R Smith; Gregory D Gromowski; Stephen Higgs; Richard M Kinney; Alan D T Barrett
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response.

Authors:  Stephane Daffis; Helen M Lazear; Wen Jun Liu; Michelle Audsley; Michael Engle; Alexander A Khromykh; Michael S Diamond
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture.

Authors:  Alexander T Ciota; Amy O Lovelace; Kiet A Ngo; An N Le; Joseph G Maffei; Mary A Franke; Anne F Payne; Susan A Jones; Elizabeth B Kauffman; Laura D Kramer
Journal:  Virology       Date:  2006-09-11       Impact factor: 3.616

8.  Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas.

Authors:  Aaron C Brault; Stanley A Langevin; Wanichaya N Ramey; Ying Fang; David W C Beasley; Christopher M Barker; Todd A Sanders; William K Reisen; Alan D T Barrett; Richard A Bowen
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

9.  Role of the mutant spectrum in adaptation and replication of West Nile virus.

Authors:  Alexander T Ciota; Kiet A Ngo; Amy O Lovelace; Anne F Payne; Yangsheng Zhou; Pei-Yong Shi; Laura D Kramer
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

10.  Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells.

Authors:  Shuetsu Fukushi; Tetsuya Mizutani; Kouji Sakai; Masayuki Saijo; Fumihiro Taguchi; Masaru Yokoyama; Ichiro Kurane; Shigeru Morikawa
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.